Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
Status:
RECRUITING
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
Dr. Nanette Santoro proposes to test the specific question that obesity results in abnormal estradiol response at the level of the pituitary and hypothalamus. This will be shown in diminished pituitary sensitivity to gonadorelin releasing hormone with a reduced estradiol induced luteinizing hormone surge in obese women.
Phase:
PHASE2
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
Colorado Clinical & Translational Sciences Institute